Document Detail


Overactivation of Ras signaling pathway in CD133+ MPNST cells.
MedLine Citation:
PMID:  22484909     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Cancer stem cells (CSCs) are believed to be the regenerative pool of cells responsible for repopulating tumors. Gaining knowledge about the signaling characteristics of CSCs is important for understanding the biology of tumors and developing novel anti-cancer therapies. We have identified a subpopulation of cells positive for CD133 (a CSC marker) from human primary malignant peripheral nerve sheath tumor (MPNST) cells which were absent in non-malignant Schwann cells. CD133 was also found to be expressed in human tissue samples and mouse MPNST cells. CD133+ cells were capable of forming spheres in non-adherent/serum-free conditions. The activation levels of Ras and its downstream effectors such as ERK, JNK, PI3K, p38K, and RalA were significantly increased in this population. Moreover, the CD133+ cells showed enhanced invasiveness which was linked to the increased expression of β-Catenin and Snail, two important proteins involved in the epithelial to mesenchymal transition, and Paxilin, a focal adhesion protein. Among other important characteristics of the CD133+ population, endoplasmic reticulum stress marker IRE1α was decreased, implying the potential sensitivity of CD133+ to the accumulation of unfolded proteins. Apoptotic indicators seemed to be unchanged in CD133+ cells when compared to the wild (unsorted) cells. Finally, in order to test the possibility of targeting CD133+ MPNST cells with Ras pathway pharmacological inhibitors, we exposed these cells to an ERK inhibitor. The wild population was more sensitive to inhibition of proliferation by this inhibitor as compared with the CD133+ cells supporting previous studies observing enhanced chemoresistance of these cells.
Authors:
Emma Borrego-Diaz; Kaoru Terai; Kristina Lialyte; Amanda L Wise; Tuba Esfandyari; Fariba Behbod; Victor F Mautner; Melanie Spyra; Sarah Taylor; Luis F Parada; Meena Upadhyaya; Faris Farassati
Related Documents :
393709 - Combined microspectrophotometry and automated quantitative autoradiography applied to t...
19463939 - Metabolic flux and cell cycle analysis indicating new mechanism underlying process osci...
7828729 - Identification of two cell cycle regulated genes affecting the beta 1,3-glucan content ...
8763499 - How viral oncogenes make the cell cycle.
8271239 - Mast cells in the harderian gland of female syrian hamsters during the estrous cycle an...
9683889 - The plasmodium cell-cycle: facts and questions.
6092769 - Pathogenesis of tumor desmoplasia. ii. collagens synthesized by line 1 and line 10 guin...
415859 - Conservation of active ribosomes in acetone-treated cells of tetrahymena pyriformis.
2076549 - Dynamic changes of microtubule and actin structures in cv-1 cells during electrofusion.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-4-8
Journal Detail:
Title:  Journal of neuro-oncology     Volume:  -     ISSN:  1573-7373     ISO Abbreviation:  -     Publication Date:  2012 Apr 
Date Detail:
Created Date:  2012-4-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8309335     Medline TA:  J Neurooncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
KUMC-Molecular Medicine Laboratory, Department of Medicine, The University of Kansas Medical Center, 3901-Rainbow Blvd, 1000 Hixon-Mail Stop: 4037, Kansas city, KS, 66160, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibition of ARNT severely compromises endothelial cell viability and function in response to moder...
Next Document:  Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor ...